Adage Capital Partners’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.6M | Buy |
3,013,009
+1,062,359
| +54% | +$19.2M | 0.09% | 219 |
|
|
2025
Q1 | $39.9M | Buy |
1,950,650
+900,650
| +86% | +$18.4M | 0.07% | 270 |
|
|
2024
Q4 | $27M | Sell |
1,050,000
-330,000
| -24% | -$8.48M | 0.05% | 359 |
|
|
2024
Q3 | $22.9M | Sell |
1,380,000
-150,000
| -10% | -$2.49M | 0.04% | 421 |
|
|
2024
Q2 | $29.4M | Sell |
1,530,000
-294,601
| -16% | -$5.66M | 0.05% | 341 |
|
|
2024
Q1 | $43.2M | Buy |
1,824,601
+524,601
| +40% | +$12.4M | 0.08% | 257 |
|
|
2023
Q4 | $14.5M | Buy |
1,300,000
+100,000
| +8% | +$1.12M | 0.03% | 516 |
|
|
2023
Q3 | $11.1M | Hold |
1,200,000
| – | – | 0.03% | 539 |
|
|
2023
Q2 | $14.3M | Buy |
+1,200,000
| New | +$14.3M | 0.03% | 493 |
|